This was the stock's second consecutive day of losses.

Last week, readers were most interested in a story about Waters acquiring BD's biosciences and diagnostics solutions business.

Chloraprep, a skin antiseptic device, celebrates 25 years in market. Becton Dickinson's El Paso plant manufactures 585 ...

Dividend stocks that reliably increase their dividends are the perfect pick for income investors. Buying reliable dividend ...

Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Waters Corporation (NYSE: WAT) and Becton, ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

Bank of New York Mellon logged higher-than-expected earnings and revenue in the second quarter, helped by its fast-growing net interest income. Dave & Buster's Entertainment named Tarun Lal as chief ...

According to Benzinga Pro, Becton Dickinson's peer group average for short interest as a percentage of float is 4.29%, which ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...